Ligand Pharmaceuticals (LGND) Goodwill & Intangibles (2010 - 2026)

Ligand Pharmaceuticals' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $318.9 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 11.4% year-over-year to $318.9 million; the TTM figure through Mar 2026 stood at $318.9 million (down 11.4% YoY), while the FY2025 annual figure was $327.0 million, down 12.08% from the prior year.
• Goodwill & Intangibles came in at $318.9 million for Q1 2026 at Ligand Pharmaceuticals, down from $327.0 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $709.6 million in Q2 2022 to a low of $303.3 million in Q4 2023.
• A 5-year average of $408.0 million and a median of $371.9 million in 2024 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles plunged 39.25% in 2023 and advanced 22.61% in 2024, its largest moves.
• Ligand Pharmaceuticals' Goodwill & Intangibles stood at $342.5 million in 2022, then decreased by 11.43% to $303.3 million in 2023, then grew by 22.61% to $371.9 million in 2024, then fell by 12.08% to $327.0 million in 2025, then slipped by 2.48% to $318.9 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $318.9 million, $327.0 million, and $335.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison